4.5 Article

Temozolomide (Temodar)

Journal

AMERICAN JOURNAL OF NEURORADIOLOGY
Volume 31, Issue 8, Pages 1383-1384

Publisher

AMER SOC NEURORADIOLOGY
DOI: 10.3174/ajnr.A2170

Keywords

-

Ask authors/readers for more resources

Temozolomide, an oral alkylating agent, is a commonly used medicine in the treatment of anaplastic astrocytoma and glioblastoma multiforme. This paper will present the mechanism of action as well as the clinical role for this chemotherapeutic drug.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available